Treatment Outcomes
7
2
3
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Risk Analysis of Intracranial Aneurysm Rupture Through Social Determinants of Health
Epithelioid Haemangioendothelioma Observational Study
GUARD-PH: Guided Use of AI-ECG for Risk Detection of PH in Surgery (GUARD-PH Trial)
Exercise Prescription in Cardiac Rehabilitation Mediated by Autonomic Function
Prehabilitation for Ovarian Cancer Patients
Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae
Probiotics in Enteral Feeding in Critically Ill Patients